On top of that, the scientists identified the ACKR3 receptor at significant amounts in crucial brain locations that are also vital opioid action centers.These results suggest that conolidine is ready to limit the ACKR3 receptor’s damaging regulatory Qualities and unencumber opioid peptides, allowing them to bind into the classical opioid receptor